Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Treatment of EGFR Mutation-Negative Metastatic Non-Small Cell Lung Cancer (NSCLC)

To see the complete question and investigator responses, move your mouse over the related topic.
Click the "Select Faculty Commentary" button to review full commentary (login required).